EP3054957
Breyting á blóðkornahlutföllum með háþrýstiinnspýtingu testósteróns með aðstoð nálar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.10.2014EP published:
2.10.2019EP application number:
14852485.3
EP translation filed:
4.11.2019Grant published:
15.11.2019EPO information:
European Patent Register
Max expiry date:
6.10.2034Expiry date:
6.10.2026Next due date:
31.10.2026
Title:
HEMATOCRIT MODULATION THROUGH NEEDLE ASSISTED JET INJECTION OF TESTOSTERONE
Timeline
Today
7.10.2014EP application
2.10.2019EP Publication
4.11.2019Translation submitted
15.11.2019Registration published
6.10.2026Expires
Owner
Name:
Antares Pharma, Inc.Address:
100 Princeton South Corporate Center, Suite 300, 08628, Ewing, NJ, US
Inventor
Name:
WOTTON, Paul K.Address:
Newton, PA, US
Name:
JAFFE, JonathanAddress:
Annandale, NJ, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361887643 PDate:
7.10.2013Country:
US
Classification
Categories:
A61K 31/56, A61P 15/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 3.1.2020
Expires: 6.10.2020
Payer: Árnason Faktor ehf.
Number: 7
Paid: 27.10.2020
Expires: 6.10.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 7.10.2021
Expires: 6.10.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 18.10.2022
Expires: 6.10.2023
Payer: Patice ehf.
Number: 10
Paid: 25.10.2023
Expires: 6.10.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 22.10.2024
Expires: 6.10.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 22.10.2025
Expires: 6.10.2026
Payer: Árnason Faktor ehf.